Dr. Reddys Labs (RDY) Posts Improved Q2 EPS of 50c/Share
Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.50, versus $0.30 reported last year. Revenue for the quarter came in at $544 million, versus $429 million reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
